| Preanalytical stability of piperacillin, tazobactam, meropenem, and ceftazidime in plasma and whole blood using liquid chromatography–tandem mass spectrometry JS Mortensen, BP Jensen, M Zhang, M Doogue Therapeutic Drug Monitoring 41 (4), 538-543, 2019 | 36 | 2019 |
| Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl) amino] octanoate (SNAC) JS Mortensen, SSR Bohr, S Harloff-Helleberg, NS Hatzakis, L Saaby, ... Journal of Controlled Release 352, 163-178, 2022 | 8 | 2022 |
| Barrier properties of ex vivo porcine intestinal mucus are highly independent of isolation and storage conditions JS Mortensen, L Saaby, S Harloff-Helleberg, HM Nielsen European Journal of Pharmaceutics and Biopharmaceutics 174, 106-110, 2022 | 8 | 2022 |
| Preanalytical stability of flucloxacillin, piperacillin, tazobactam, meropenem, cefalexin, cefazolin, and ceftazidime in therapeutic drug monitoring: a structured review JS Mortensen, BP Jensen, M Doogue Therapeutic Drug Monitoring 44 (6), 709-719, 2022 | 6 | 2022 |
| Overcoming the mucus barrier JS Mortensen, MB Stie, S Harloff-Helleberg, HM Nielsen Organelle and molecular targeting, 355-380, 2021 | 3 | 2021 |
| Effects of prophylactic antibiotics administration on barrier properties of intestinal mucosa and mucus from preterm born piglets JS Mortensen, DN Nguyen, H Mørck Nielsen, S Rønholt Drug Delivery and Translational Research 13 (5), 1456-1469, 2023 | 1 | 2023 |
| Neonatal intestinal mucus barrier changes in response to maturity, inflammation, and sodium decanoate supplementation JS Mortensen, SSR Bohr, LS Krog, JP Bøtker, V Kapousidou, L Saaby, ... Scientific Reports 14 (1), 7665, 2024 | | 2024 |
